SCHEMBL17750

SCHEMBL17750

CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@H]2CN2CCOCC2)cc1)C(F)(F)F

nearest known ligand 0.86

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 8/20 0.86
GCK P35557 12/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12078897 1.00 GCKR (0.86) GCKRGCK
SCHEMBL17889 1.00 GCKR (0.86) GCKRGCK
SCHEMBL12078954 1.00 GCKR (0.86) GCKRGCK
SCHEMBL18013 1.00 GCKR (0.86) GCKRGCK
SCHEMBL16116 1.00 GCKR (0.86) GCKRGCK
SCHEMBL16514 1.00 GCKR (0.86) GCKRGCK
SCHEMBL12089229 0.92 GCKR (0.81) GCKRGCK
SCHEMBL12089479 0.92 GCKR (0.81) GCKRGCK
SCHEMBL12089476 0.92 GCKR (0.81) GCKRGCK
SCHEMBL23763 0.92 GCK (0.81) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed